...
首页> 外文期刊>Progress in Neurobiology: An International Review Journal >Behavioral, neurochemical, anatomical and electrophysiological correlates of panic disorder: multiple transmitter interaction and neuropeptide colocalization.
【24h】

Behavioral, neurochemical, anatomical and electrophysiological correlates of panic disorder: multiple transmitter interaction and neuropeptide colocalization.

机译:恐慌症的行为,神经化学,解剖学和电生理学相关性:多种递质相互作用和神经肽共定位。

获取原文
           

摘要

Neurochemical accounts of panic disorder focus on peripheral indices of central transmitter activity, hormonal correlates and therapeutic efficacy. Anxiogenic agents augment norepinephrine activity, some anxiolytics increase serotonin neurotransmission while benzodiazepines and antidepressants influence catecholamine, indoleamine and gamma-aminobutyric acid turnover in infrahuman subjects. Reliable correlates of central transmitter activity in panic disorder are not in evidence. While animal models of anxiety may not mirror the symptom profile of panic, neurobiological accounts of panic disorder fail to consider extensive central colocalization of neurotransmitter and putative neurotransmitters. In effect, transmitter release in major ascending and descending transmitter systems is modulated by variable neuropeptide interfacing. The behavioral concomitants of psychological disturbance likely follow from variable neurochemical release induced by stimuli as well as conditioning and sensitization. The functional role of receptor sites associated with multiple neurochemical systems may vary and the sensitivity and/or density of receptor sites may be modified. Accordingly, the behavioral and neurochemical concomitants of acute and chronic pathology may be fundamentally different from one another. The present review argues that the symptoms of panic disorder and the etiology of the illness must be evaluated against a background of genetic, organismic and experiential factors. Such variables presumably underlie the diverse behavioral symptoms associated with panic disorder and variations in the therapeutic efficacy of pharmacological treatment.
机译:恐慌症的神经化学作用集中在中枢递质活性,激素相关性和治疗功效的外周指标上。促焦虑药可增强去甲肾上腺素的活性,某些抗焦虑药可增加5-羟色胺的神经传递,而苯二氮卓类和抗抑郁药会影响儿科动物体内儿茶酚胺,吲哚胺和γ-氨基丁酸的代谢。恐慌症中中央递质活动的可靠相关性尚无证据。虽然焦虑症的动物模型可能无法反映恐慌的症状特征,但恐慌症的神经生物学解释未能考虑到神经递质和推定神经递质的广泛中央共定位。实际上,主要的上升和下降递质系统中的递质释放是通过可变的神经肽接口来调节的。心理障碍的行为伴随者可能来自刺激以及条件调节和敏化引起的可变的神经化学释放。与多个神经化学系统相关的受体位点的功能作用可以改变,并且可以修饰受体位点的敏感性和/或密度。因此,急性和慢性病理的行为和神经化学伴随可能彼此根本不同。本文认为,恐慌症的症状和病因必须在遗传,机体和经验因素的背景下进行评估。这些变量大概是与惊恐症和药理学治疗功效变化有关的各种行为症状的基础。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号